Edgemond James's Form 4 filing
United Therapeutics Corp (UTHR) · filed Apr 10, 2026
- Accession no.
- 0001636178-26-000008
- Filed
- Apr 10, 2026
- Trade date
- Apr 9, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.78M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Edgemond JamesCIK 0001636178 | Officer (CFO AND TREASURER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Common Stock | MOption exerciseAcquired | +10,000 | $135.42 | +$1,354,200 | 28,876 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −560 | $574.87F2 | −$321,927.2 | 28,316 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −1,956 | $575.53F3 | −$1,125,736.68 | 26,360 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −1,586 | $576.63F4 | −$914,535.18 | 24,774 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −1,617 | $577.77F5 | −$934,254.09 | 23,157 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −1,139 | $578.52F6 | −$658,934.28 | 22,018 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −1,224 | $579.75F7 | −$709,614 | 20,794 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −1,756 | $580.64F8 | −$1,019,603.84 | 19,038 | Direct | |
| Apr 9, 2026 | Common Stock | SSaleDisposed | −162 | $582.30F9 | −$94,332.6 | 18,876 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 102,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $574.18 to $575.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $575.18 to $576.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $576.18 to $577.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $577.19 to $578.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $578.22 to $579.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $579.24 to $580.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $580.24 to $581.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $581.25 to $581.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.